Search Results

Civica Inc. is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.

Starting today, global healthcare company AmerisourceBergen will serve as Civica, Inc.’s (Civica) exclusive distribution partner and provide supply chain support for Civica’s products and a best-in-class customer experience for Civica members.

Civica Inc. announced that biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer.

Onshoring pharmaceutical manufacturing has become a priority in the United States and is even backed by a $2 billion federal investment.

Civica Rx welcomes the findings of the 100-day supply chain review. The report identifies key vulnerabilities in the generic drug supply chain that contribute to drug shortages and supply risks during a global public health emergency.

CivicaScriptTM, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and EmsanaRx, PBC, the only pharmacy benefit manager built by employers, for employers, announced that EmsanaRx is joining CivicaScript as a partnering member.

Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, and CivicaScript,TM a statutory public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, announced today that Navitus has joined CivicaScript as a founding member.

The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients

Civica Rx announced that CivicaScript is the name for its operating unit dedicated to lowering the cost of select high-cost generic medicines, and that one of the nation’s largest health insurers and a leading drug manufacturer are joining the initiative.